OBJECTIVE: To compare the safety and perioperative outcomes of robotic versus laparoscopic retroperitoneal lymph node dissection (RPLND).
PATIENTS AND METHODS: Our institutional review board approved retrospective testicular cancer registry was queried for patients who underwent a primary unilateral robotic (R-RPLND) or laparoscopic (L-RPLND) RPLND by a single surgeon for a stage I testicular nonseminomatous germ cell tumor. Groups were compared for differences in baseline and outcomes variables.
RESULTS: Between July 2006 and July 2014, a total of 16 R-RPLND and 21 L-RPLND cases were performed by a single surgeon. Intra- and perioperative outcomes including operative time, estimated blood loss, lymph node yield, complicate rate and ejaculatory status were similar between groups (all p > 0.1).
CONCLUSIONS: As an early checkpoint, R-RPLND appears comparable to the laparoscopic approach in terms of safety and perioperative outcomes. It remains unclear if R-RPLND offers any tangible benefits over standard laparoscopy.
Harris KT, Gorin MA, Ball MW, Pierorazio PM, Allaf ME.
The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Reference: BJU Int. 2015 Mar 17. Epub ahead of print.